- Home
- CPAC vs MAZE Comparison
CPAC vs MAZE Comparison
Compare CPAC & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- MAZE
- Stock Information
- Founded
- CPAC 1949
- MAZE 2018
- Country
- CPAC Peru
- MAZE United States
- Employees
- CPAC N/A
- MAZE N/A
- Industry
- CPAC Building Materials
- MAZE
- Sector
- CPAC Industrials
- MAZE
- Exchange
- CPAC Nasdaq
- MAZE NYSE
- Market Cap
- CPAC 505.3M
- MAZE 523.1M
- IPO Year
- CPAC 2012
- MAZE 2025
- Fundamental
- Price
- CPAC $5.81
- MAZE $10.37
- Analyst Decision
- CPAC Sell
- MAZE Strong Buy
- Analyst Count
- CPAC 1
- MAZE 3
- Target Price
- CPAC $6.00
- MAZE $25.67
- AVG Volume (30 Days)
- CPAC 3.1K
- MAZE 318.8K
- Earning Date
- CPAC 04-28-2025
- MAZE 01-01-0001
- Dividend Yield
- CPAC 8.63%
- MAZE N/A
- EPS Growth
- CPAC 17.75
- MAZE N/A
- EPS
- CPAC 0.12
- MAZE 1.25
- Revenue
- CPAC $524,464,683.00
- MAZE $167,500,000.00
- Revenue This Year
- CPAC N/A
- MAZE N/A
- Revenue Next Year
- CPAC N/A
- MAZE N/A
- P/E Ratio
- CPAC $9.51
- MAZE $8.28
- Revenue Growth
- CPAC 1.44
- MAZE N/A
- 52 Week Low
- CPAC $5.10
- MAZE $9.50
- 52 Week High
- CPAC $6.65
- MAZE $17.00
- Technical
- Relative Strength Index (RSI)
- CPAC 54.59
- MAZE N/A
- Support Level
- CPAC $5.71
- MAZE N/A
- Resistance Level
- CPAC $5.95
- MAZE N/A
- Average True Range (ATR)
- CPAC 0.03
- MAZE 0.00
- MACD
- CPAC 0.01
- MAZE 0.00
- Stochastic Oscillator
- CPAC 100.00
- MAZE 0.00
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.